Initial results of inflammatory response, matrix remodeling, and reactive oxygen species following PCI in acute ischemic myocardial injury in man

Journal of Invasive Cardiology

Volumn 23, Issue 9, 2011, Pages 371-376

  Hedström, Erik ^a   Åström Olsson, Karin ^a   Öhlin, Ann Kristin ^b   Öhlin, Hans ^a   Arheden, Håkan ^a  

^a Department of Clinical Physiology ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

biomarkers; infarct size; myocardial; myocardium at risk; salvage; stunning

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE; MALONALDEHYDE; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONVALESCENCE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INFLAMMATION; MALE; PERCUTANEOUS CORONARY INTERVENTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACUTE DISEASE; ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING, CINE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; NEUTROPHILS; REACTIVE OXYGEN SPECIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80855124038     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hedström E, Engblom H, Frogner F, et al. Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species-implications for assessment of myocardial salvage. JCMR. 2009;11:38.
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-360.
3. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76:1713-1719. (Pubitemid 16196036)
4. Jennings R, Reimer K. Lethal reperfusion injury: fact or fancy? Myocardial Response to Acute Injury. Parratt JR (ed). 1992: pp. 17-34.
5. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol. 1988;12:239-249.
6. Bolli R, Zhu WX, Hartley CJ, et al. Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea. Circulation. 1987;76:458-468. (Pubitemid 17124750)
7. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 2004;61:481-497. (Pubitemid 38210154)
8. Libby P, Maroko PR, Bloor CM, et al. Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest. 1973;52:599-607.
9. Crawford MH, Grover FL, Kolb WP, et al. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation. 1988;78:1449-1458. (Pubitemid 19004247)
10. Mullane KM, Read N, Salmon JA, et al. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther. 1984;228:510-522. (Pubitemid 14190764)
11. Baran KW, Nguyen M, McKendall GR, et al. Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study Group. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study. Circulation. 2001;104:2778-2783. (Pubitemid 33126650)
12. Dove A. CD18 trials disappoint again. Nat Biotechnol. 2000;18:817-818. (Pubitemid 30640897)
13. Roberts R, DeMello V, Sobel BE. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation. 1976;53:I204-1206.
14. Rusnak JM, Kopecky SL, Clements IP, et al. An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). Am J Cardiol. 2001;88:482-487. (Pubitemid 32778491)
15. Åström-Olsson K, Hedström E, Hultén LM, et al. Dissociation of the inflammatory reaction following PCI for acute myocardial infarction. J Invasive Cardiol. 2007;19:452-456. (Pubitemid 350071384)
16. Bell D, Jackson M, Nicoll JJ, et al. Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment. Br Heart J. 1990;63:82-87. (Pubitemid 20053769)
17. Lalu MM, Pasini E, Schulze CJ, et al. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur Heart J. 2005;26:27-35. (Pubitemid 40221120)
18. Hemdahl AL, Gabrielsen A, Zhu C, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2006;26:136-142. (Pubitemid 43732240)
19. Puhakka M, Magga J, Hietakorpi S, et al. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Card Fail. 2003;9:325-332. (Pubitemid 37048026)
20. Smit JJ, Ottervanger JP, Slingerland RJ, et al. On-TIME Study Group. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol. 2008;101:446-451. (Pubitemid 351199429)
21. Lu L, Gunja-Smith Z, Woessner JF, et al. Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am J Physiol/Heart Circ Physiol. 2000;279:H601-609.
22. Engblom H, Hedström E, Heiberg E, et al. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI. Circ Cardiovasc Imaging. 2009;2:47-55.
23. Soneson H, Ubachs JF, Ugander M, et al. An improved method for automatic segmentation of the left ventricle in myocardial perfusion SPECT. J Nucl Med. 2009;50:205-213.
24. Soneson H, Engblom H, Hedström E, et al. An automatic method for quantification of myocardium at risk from myocardial perfusion SPECT in patients with acute coronary occlusion. J Nucl Cardiol. 2010;17:831-840.
25. Heiberg E, Ugander M, Engblom H, et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology. 2008;246:581-588.
26. Baxter GF. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol. 2002;97:268-275. (Pubitemid 34808773)
27. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985;14:157-167. (Pubitemid 15241170)
28. Gwechenberger M, Mendoza LH, Youker KA, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 1999;99:546-551. (Pubitemid 29061871)
29. Gallucci RM, Simeonova PP, Matheson JM, et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 2000;14:2525-2531.
30. Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
31. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 1999;43:860-878. (Pubitemid 29413185)
32. Go LO, Murry CE, Richard VJ, et al. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. Am J Physiol. 1988;255:H1188-H1198.
33. Juneau CF, Ito BR, del Balzo U, et al. Severe neutrophil depletion by leucocyte filters or cytotoxic drug does not improve recovery of contractile function in stunned porcine myocardium. Cardiovasc Res. 1993;27:720-727. (Pubitemid 23162662)
34. Karlsson K, Marklund SL. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J. 1987;242:55-59. (Pubitemid 17015446)
35. Lincoff AM, Kereiakes DJ, Mascelli MA, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation. 2001;104:163-167. (Pubitemid 32655832)
36. Neumann FJ, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1420-1426.
37. Carlsson M, Ubachs JF, Hedström E, et al. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging. 2009;2:569-576.